ICCM · IceCure Medical Ltd. · Metrics
Market Cap
$4.68M
Shares
4.64M
Volume · Oct 26
103.79K
Avg daily vol (3M)
144.62K
ICCM metrics
60 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$1.03
Market cap
$4.68M
Price action
20 metricsPrice change (1W)
-4.7%
Price change (30D)
-38.0%
Price change (3M)
-67.2%
Price change (6M)
—
Price change (YTD)
—
Price change (1Y)
—
Trailing year
Price change (5Y)
—
52-week high
—
52-week low
—
Change from 52-week high
—
Change from 52-week low
—
Annualized volatility
351.9%
Annualized volatility (3M)
71.7%
Beta
—
RSI (14D)
21.4
Price vs SMA 50
-44.7%
Price vs SMA 200
—
Avg volume (3M)
144,184
Relative volume
0.3
Average dollar volume
$282,735
Company
3 metricsSector
Healthcare
Industry
Medical Devices
Shares outstanding
4.64M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.2×
reciprocal yield 84.3%
P / book
0.4
reciprocal yield 253.9%
FCF yield
-340.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-360.3%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-08-12
Profitability
9 metricsGross margin
36.1%
Operating margin
-423.7%
Trailing 12 months
Net margin
-427.7%
Gross profit (TTM)
$1.43M
Operating profit (TTM)
−$16.72M
Net income (TTM)
−$16.88M
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
-403.9%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+2.7%
Year over year
Net income growth YoY
—
Revenue (TTM)
$3.95M
Trailing 12 months
EPS growth YoY
-20.0%
Shares change YoY
+25.0%
Year over year · more shares
Revenue CAGR (3Y)
+3.1%
Revenue CAGR (5Y)
-2.7%
EPS CAGR (3Y)
-19.5%
EPS CAGR (5Y)
+1.8%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-141.9%
Return on assets
-95.3%
Debt / equity
—
Current ratio
2.9
EBITDA (TTM)
—
Free cash flow (TTM)
−$15.94M
Quick ratio
2.4
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$12.03M
Total assets
$17.71M
Total debt
—
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$15.87M
Capital expenditures (TTM)
$69,000
R&D (TTM)
$8.34M
SG&A (TTM)
—
Stock compensation (TTM)
$1.38M
R&D / revenue
211.2%
Stock compensation / revenue
34.9%
Ownership (13F)
9 metrics13F filers
11
13F filer change QoQ
-7
Institutional ownership
2.8%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+19.3%
Holder tenure
3.3
Price vs estimated holder cost
-77.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.9%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
23 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—